NLS Acquisition

AstraZeneca has announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomics™, which dramatically improves the identification of biomarkers in tumour tissue. Under the terms of the agreement, MedImmune will […]

As part of the financing of the acquisition of Rottapharm, Meda’s Board of Directors has resolved to launch a rights issue of approximately SEK 2.0 billion. On 31 July 2014, Meda announced entering into an agreement to acquire the Italian specialty pharma company Rottapharm S.p.A. Completion of the transaction was subject to certain conditions, including […]

Cadila Pharmaceuticals Sweden AB has announced the acquisition of Swedish BioChromix NewCo. BioChromix NewCo was founded in 2013, based the technology previously developed by BioChromix AB and BioChromix Pharma AB, to explore a class of conjugated heteocyclic compounds for the treatment of protein misfolding. Cadila Pharmaceuticals will continue to develop the preclinical and clinical development […]

Addvise Lab Solutions AB has entered into an agreement to acquire Surgical Tables Inc for SEK 18.2 million. The agreement is planned to be effective November 1, 2014. Approximately SEK 5,5 million will be paid in cash at closing and approximately SEK 5,5 million is paid in newly issued shares or in cash at closing. Also, approximately SEK […]

The acquisition of NMT, Nordisk Medicin & Teknik AB, a medtech agency company that markets and sells urology products, will cost ProstaLund approximately SEK 4 million. Buying NMT will complete ProstaLund’s current product portfolio and increase the corporate group’s revenues with SEK 5 million on an annual basis, states ProstaLund. The acquisition is part of […]

Elekta has announced its intention to acquire RTA, a leading distributor from Poland specializing in radiation therapy technologies. Elekta states that the acquisition will significantly strengthen Elekta’s position in the Polish cancer care market. “The acquisition of RTA would optimally position Elekta to capture the opportunities for the growth of radiation therapy in Poland. Developing the […]